These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1925165)

  • 1. Using provisional diagnoses in monitoring a clinical trial.
    Karon JM
    Stat Med; 1991 Sep; 10(9):1341-8. PubMed ID: 1925165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.
    J Chronic Dis; 1979; 32(9-10):609-31. PubMed ID: 489702
    [No Abstract]   [Full Text] [Related]  

  • 3. Participant recruitment to the Lipid Research Clinics Coronary Primary Prevention Trial.
    Bradford RH
    Control Clin Trials; 1987 Dec; 8(4 Suppl):31S-40S. PubMed ID: 3440388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From clinical trials to clinical practice: generalizing from participant to patient.
    Rubins HB
    Control Clin Trials; 1994 Feb; 15(1):7-10. PubMed ID: 8149772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Kronmal RA
    JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
    [No Abstract]   [Full Text] [Related]  

  • 7. A proposed statistical framework for the management of subgroup analyses for large clinical trials.
    Luo X; Chen P; Wu AC; Pan G; Li M; Chen G; Dong Q; Cline GA; Dornseif BE; Jin Z
    Contemp Clin Trials; 2015 Nov; 45(Pt B):239-243. PubMed ID: 26388115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Research Clinics Coronary Primary Prevention Trial. Reply to commentary by Richard Kronmal. By the Lipid Research Clinics Program investigators.
    JAMA; 1985 Jul; 254(2):263-4. PubMed ID: 3999371
    [No Abstract]   [Full Text] [Related]  

  • 9. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trials of primary prevention by diet or hypolipidemic treatment].
    Richard JL
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():97-103. PubMed ID: 1285703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues.
    Grayston JT; Jackson LA; Kennedy WJ; Kronmal RA
    Am Heart J; 1999 Nov; 138(5 Pt 2):S545-9. PubMed ID: 10539871
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholesterol and cardiovascular disease. An overview of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC Coronary Primary Prevention Trial.
    Tyroler HA
    Am J Cardiol; 1984 Aug; 54(5):14C-19C. PubMed ID: 6382998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels.
    Sacks FM; Rouleau JL; Moye LA; Pfeffer MA; Warnica JW; Arnold JM; Nash DT; Brown LE; Sestier F; Rutherford J
    Am J Cardiol; 1995 Mar; 75(8):621-3. PubMed ID: 7887392
    [No Abstract]   [Full Text] [Related]  

  • 14. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
    Ansell BJ; Watson KE; Fogelman AM
    JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalizing from clinical trials.
    Davis CE
    Control Clin Trials; 1994 Feb; 15(1):11-4. PubMed ID: 8149768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of clinical trials: proving the lipid hypothesis.
    Brown WV
    Eur Heart J; 1990 Dec; 11 Suppl H():15-20. PubMed ID: 2073909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials including an update on the Helsinki Heart Study.
    Brown WV
    Am J Cardiol; 1990 Sep; 66(6):11A-15A. PubMed ID: 2203244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and design of the ViCTORY (Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY) trial.
    Min JK; Arsanjani R; Kurabayashi S; Andreini D; Pontone G; Choi BW; Chang HJ; Lu B; Narula J; Karimi A; Roobottom C; Gomez M; Berman DS; Cury RC; Villines T; Kang J; Leipsic J
    J Cardiovasc Comput Tomogr; 2013; 7(3):200-6. PubMed ID: 23849493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.